Drug Profile
Interleukin-2 gene therapy - Transgene
Alternative Names: Ad-IL2; Adeno-IL2; TG 1024; Vero-IL-2Latest Information Update: 06 Feb 2017
Price :
$50
*
At a glance
- Originator Transgene
- Class Antineoplastics; Cytokine genes; Gene therapies; Interleukins
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Gastrointestinal cancer; Lung cancer; Malignant melanoma; Mesothelioma; Renal cancer; Solid tumours
Most Recent Events
- 06 Feb 2017 Discontinued - Phase-I/II for Malignant melanoma in Switzerland (Injection)
- 06 Feb 2017 Discontinued - Phase-I/II for Renal cancer in Switzerland (Injection)
- 06 Feb 2017 Discontinued - Phase-I/II for Solid tumours in Switzerland (Injection)